Jienchi Dorward - Concepedia

Author

Jienchi Dorward

Centre for the AIDS Programme of Research in South Africa ORCID

Also Known As

Dorward Jienchi, J. Dorward, Jienchi Dorward, Jienchi J. Dorward, Mona Bafadhel, PRINCIPLE Trial Collaborative Group, Yu, L-M

115

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Centre for the AIDS Programme of Research in South Africa University of KwaZulu-Natal University of Oxford eThekwini Municipality University of Washington

About

Jienchi Dorward is an author at Centre for the AIDS Programme of Research in South Africa specializing in medicine, public health, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	1.4K
2	Public Health	6	6	641
3	Epidemiology	5	6	1.2K
4	Nursing	3	3	154
5	Global Health	1	1	107

Jienchi Dorward

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study Simon de Lusignan, Jienchi Dorward, Ana Correa, The Lancet Infectious Diseases	2020	665
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial Christopher Butler, Richard Hobbs, Oghenekome Gbinigie, The Lancet Long CovidTreatment And PreventionCovid-19 PandemicAdverse OutcomesAntiviral Therapy	2022	391
The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis Jienchi Dorward, Thokozani Khubone, Kelly Gate, The Lancet HIV	2021	313
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Christopher Butler, Jienchi Dorward, Ly‐Mee Yu, The Lancet	2021	306
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Ly‐Mee Yu, Mona Bafadhel, Jienchi Dorward, The Lancet EpidemiologyRespiratory DiseasesMedicineRespiratory InfectionInfectious Respiratory Disease	2021	302
Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial Paul K. Drain, Jienchi Dorward, Lauren R. Violette, The Lancet HIV NursingSexual HealthPoint-of-care TestingTreatment And PreventionClinical Trials	2020	109
Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research Jienchi Dorward, Richard Lessells, Paul K. Drain, The Lancet HIV Preventive MedicineTreatment And PreventionGlobal HealthFirst-line Antiretroviral TherapyInternational Health	2018	107
Developing oligodendrocytes express functional GABA<sub>B</sub> receptors that stimulate cell proliferation and migration Karen Luyt, Timothy P. Slade, Jienchi Dorward, Journal of Neurochemistry	2006	94
The Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Protocol to Develop Extended COVID-19 Surveillance and Trial Platforms Simon de Lusignan, Nicholas Jones, Jienchi Dorward, JMIR Public Health and Surveillance	2020	77
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Christopher Butler, Ly‐Mee Yu, Jienchi Dorward, The Lancet Respiratory Medicine Preventive MedicineTreatment And PreventionMedicineCovid-19 PandemicClinical Trials	2021	77

Page 1